Status:
COMPLETED
HRQoL During PRRT in Patients With NETs
Lead Sponsor:
Uppsala University
Conditions:
Neuroendocrine Tumors
Quality of Life
Eligibility:
All Genders
18+ years
Brief Summary
Neuroendocrine tumours (NETs) can arise in different locations in the body, and may give rise to hormonal symptoms, which may affect the patients' health-related quality of life (HRQoL). Up to four cy...
Detailed Description
The inclusion criteria for PRRT were tumour somatostatin receptor expression higher than that in the normal liver found on somatostatin receptor scintigraphy (Krenning score 3 and 4), or on 68Ga-DOTAT...
Eligibility Criteria
Inclusion
- Receiving PRRT
- NET diagnosis
Exclusion
- Not able to speak and read in Swedish or English.
Key Trial Info
Start Date :
January 10 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 10 2018
Estimated Enrollment :
756 Patients enrolled
Trial Details
Trial ID
NCT05427032
Start Date
January 10 2009
End Date
December 10 2018
Last Update
June 22 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.